Literature DB >> 16882277

Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project.

P M Nilsson1, J-A Nilsson, G Berglund.   

Abstract

AIMS: To calculate the population-attributable risk (PAR) of coronary events (CE) from 10 risk factors, during long-term follow-up.
METHODS: We used both case-cohort and case-control analyses for calculation of PAR in relation to 10 baseline risk factors. First CE (fatal or nonfatal, n=3072) in 22,444 males and 10,902 females was recorded during a mean follow-up of 20 years by use of national registers.
RESULTS: Using a Cox regression analysis in a case-cohort design, smoking (prevalence in men 49%, women 37%) was the strongest risk factor, RR 2.29 (95% CI 2.09-2.52; PAR 39%), followed by hypercholesterolaemia, RR 1.70 (95% CI 1.56-1.86; PAR 18%), and diabetes, RR 1.67 (95% CI 1.41-1.99; PAR 3%). For women the strongest risk factors were smoking, RR 3.16 (95% CI 2.50-3.98; PAR 44%), diabetes, RR 2.59 (95% CI 1.78-3.76; PAR 6%), and hypertension, RR 2.47 (95% CI 1.94-3.14; PAR 23%). In men, smoking was the strongest predictor both after 10 years [RR 2.69 (95% CI 2.23-3.24)] and 20 years [RR 2.45 (95% CI 2.15-2.79)], followed by hypercholesterolaemia (RR 2.16-1.63), hypertension (RR 2.04-1.51), and diabetes (RR 1.85 -1.47). The case-control design gave very similar results. Total PAR varied from 74% (fully adjusted Cox regression, case-control, in men) to 116% in women (case-cohort).
CONCLUSION: Smoking is the most important long-term risk factor for CE in both genders, based on data from a population with a high proportion of smokers. Ten measured variables explained almost all variation in risk and could be used as a basis for intervention programmes.

Entities:  

Mesh:

Year:  2006        PMID: 16882277     DOI: 10.1111/j.1365-2796.2006.01671.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  25 in total

1.  Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.

Authors:  Tereza Planck; Bushra Shahida; Marketa Sjögren; Leif Groop; Bengt Hallengren; Mikael Lantz
Journal:  Thyroid       Date:  2014-06-03       Impact factor: 6.568

2.  Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.

Authors:  Axel Gerdtsson; Jessica B Poon; Daniel L Thorek; Lorelei A Mucci; Michael J Evans; Peter Scardino; Per-Anders Abrahamsson; Peter Nilsson; Jonas Manjer; Anders Bjartell; Johan Malm; Andrew Vickers; Stephen J Freedland; Hans Lilja; David Ulmert
Journal:  Eur Urol       Date:  2015-03-18       Impact factor: 20.096

3.  Impact of risk factors for non-fatal acute myocardial infarction.

Authors:  Andreia Oliveira; Henrique Barros; Ana Azevedo; Joana Bastos; Carla Lopes
Journal:  Eur J Epidemiol       Date:  2009-06-04       Impact factor: 8.082

Review 4.  Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.

Authors:  Matthew Nayor; Ramachandran S Vasan
Journal:  Circulation       Date:  2016-05-03       Impact factor: 29.690

5.  Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics.

Authors:  Tereza Planck; Bushra Shahida; Johan Malm; Jonas Manjer
Journal:  Eur Thyroid J       Date:  2017-11-21

6.  Study of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population.

Authors:  Bushra Shahida; Tereza Planck; Peter Åsman; Mikael Lantz
Journal:  Eur Thyroid J       Date:  2018-07-20

7.  Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan.

Authors:  Wuan-Szu Wang; Mark L Wahlqvist; Chih-Cheng Hsu; Hsing-Yi Chang; Wan-Chi Chang; Chu-Chih Chen
Journal:  BMC Public Health       Date:  2012-02-10       Impact factor: 3.295

8.  Combined effect of low-penetrant SNPs on breast cancer risk.

Authors:  S Harlid; M I L Ivarsson; S Butt; E Grzybowska; J E Eyfjörd; P Lenner; A Försti; K Hemminki; J Manjer; J Dillner; J Carlson
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

9.  The association between cardiovascular health and health-related quality of life and health status measures among U.S. adults: a cross-sectional study of the National Health and Nutrition Examination Surveys, 2001-2010.

Authors:  Norrina B Allen; Sylvia Badon; Kurt J Greenlund; Mark Huffman; Yuling Hong; Donald M Lloyd-Jones
Journal:  Health Qual Life Outcomes       Date:  2015-09-22       Impact factor: 3.186

10.  Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controls.

Authors:  Xian-Ping Hua; Xiao-Dong Zhang; Joey Sw Kwong; Xian-Tao Zeng; Zhen-Jian Zhang; Wan-Lin Wei
Journal:  Ther Clin Risk Manag       Date:  2015-09-23       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.